All In Biotech

Drug Trial Radar · NCT00002032

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

750

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
PharmaciaPfizer (PFE)
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objectives of this trial are: To compare the safety of oral rifabutin versus placebo in the treatment of Mycobacterium avium complex (MAC) bacteremia in AIDS patients with CD4 counts less than or equal to 200 cells/mm3. To investigate the incidence of MAC in these patients. A secondary objective is to compare clinical response, quality of life (Karnofsky), and survival between these two groups.

Conditions

  • Mycobacterium Avium-intracellulare Infection
  • HIV Infections

Interventions

  • RifabutinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

33 sites in 1 country. Site status is shown where the registry gives one.

  • Ctr for Special Immunology

    Irvine, California

  • Olive View Med Ctr

    Sylmar, California

  • Denver Public Health Dept

    Denver, Colorado

  • Veterans Administration Med Ctr

    Washington D.C., District of Columbia

  • Ctr for Special Immunology

    Fort Lauderdale, Florida

  • TheraFirst Med Ctrs Inc

    Fort Lauderdale, Florida

  • Mem Hosp Hollywood

    Hollywood, Florida

  • VP Med Services / HHCS Research Institute Inc

    Orlando, Florida

  • AIDS Research Consortium of Atlanta

    Atlanta, Georgia

  • Grady Memorial Hosp / Hughs Spalding Med Ctr

    Atlanta, Georgia

  • Dr Winkler Weinberg

    Roswell, Georgia

  • Johns Hopkins School of Medicine

    Baltimore, Maryland

  • CRI of New England

    Brookline, Massachusetts

  • Univ of Missouri at Kansas City School of Medicine

    Kansas City, Missouri

  • Research Med Ctr

    Kansas City, Missouri

  • Brooklyn Veterans Administration

    Brooklyn, New York

  • Maimonides Med Ctr

    Brooklyn, New York

  • Nassau County Med Ctr

    East Meadow, New York

  • Long Island Jewish Med Ctr

    New Hyde Park, New York

  • Community Research Initiative

    New York, New York

  • Chelsea Village Med Ctr

    New York, New York

  • Mem Sloan - Kettering Cancer Ctr

    New York, New York

  • Univ Hosp of Cleveland / Case Western Reserve Univ

    Cleveland, Ohio

  • Ohio State Univ Med Ctr

    Columbus, Ohio

  • Central Texas Med Foundation

    Austin, Texas

  • Nelson Tebedo Community Clinic

    Dallas, Texas

  • Univ of Texas Southwestern Med Ctr of Dallas

    Dallas, Texas

  • Texas Tech Health Sciences Ctr

    El Paso, Texas

  • Baylor College of Medicine

    Houston, Texas

  • Houston Clinical Research Network

    Houston, Texas

  • Univ TX San Antonio Health Science Ctr

    San Antonio, Texas

  • Scott and White Hosp

    Temple, Texas

  • Dr Scott Lea

    Waco, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.